Package | Dosage | Price | Price per Dose | |
---|---|---|---|---|
Dosage: 200mg | ||||
270 pill | 200mg | NZD380.49 | NZD1.41 | |
180 pill | 200mg | NZD278.56 | NZD1.55 | |
120 pill | 200mg | NZD203.82 | NZD1.70 | |
90 pill | 200mg | NZD161.36 | NZD1.80 | |
60 pill | 200mg | NZD117.19 | NZD1.95 | |
30 pill | 200mg | NZD61.14 | NZD2.04 | |
20 pill | 200mg | NZD42.45 | NZD2.12 | |
10 pill | 200mg | NZD23.76 | NZD2.38 | |
Dosage: 400mg | ||||
270 pill | 400mg | NZD696.44 | NZD2.58 | |
180 pill | 400mg | NZD489.20 | NZD2.72 | |
120 pill | 400mg | NZD336.32 | NZD2.80 | |
90 pill | 400mg | NZD259.88 | NZD2.89 | |
60 pill | 400mg | NZD178.34 | NZD2.97 | |
30 pill | 400mg | NZD91.71 | NZD3.06 | |
20 pill | 400mg | NZD62.83 | NZD3.14 | |
10 pill | 400mg | NZD32.26 | NZD3.23 | |
Dosage: 550mg | ||||
270 pill | 550mg | NZD825.54 | NZD3.06 | |
180 pill | 550mg | NZD565.64 | NZD3.14 | |
120 pill | 550mg | NZD407.66 | NZD3.40 | |
90 pill | 550mg | NZD321.03 | NZD3.57 | |
60 pill | 550mg | NZD219.11 | NZD3.65 | |
30 pill | 550mg | NZD113.79 | NZD3.79 | |
20 pill | 550mg | NZD79.82 | NZD3.99 | |
10 pill | 550mg | NZD42.45 | NZD4.25 |

Rifaximin Description
Introduction to Rifaximin
Rifaximin is a widely used antibiotic that belongs to the class of rifamycins. It is known for its effectiveness against a variety of bacterial infections, particularly those affecting the gastrointestinal tract. Rifaximin is often prescribed to treat conditions such as traveler’s diarrhea, hepatic encephalopathy, and irritable bowel syndrome with diarrhea (IBS-D). Its mechanism of action involves inhibiting bacterial RNA synthesis, which ultimately hampers bacterial growth and proliferation. One of the key advantages of rifaximin is its broad-spectrum activity combined with minimal absorption into the bloodstream, making it suitable for targeted gastrointestinal therapy.
Effectiveness and Usage
Many patients report positive outcomes after using rifaximin for their gastrointestinal issues. For traveler’s diarrhea, it often provides rapid relief from symptoms such as diarrhea, cramping, and nausea. Its targeted action in the gut makes it effective at eradicating pathogenic bacteria without significantly affecting the body's beneficial microbiota. In cases of hepatic encephalopathy, rifaximin helps reduce the production of ammonia by intestinal bacteria, thereby decreasing the risk of brain complications associated with liver disease. For IBS-D, some studies have shown that rifaximin can improve symptoms like bloating, abdominal pain, and diarrhea, enhancing the patient's quality of life.
Safety and Side Effects
Rifaximin is generally well tolerated by most users. Since it remains largely within the gastrointestinal tract, systemic side effects are rare. However, some individuals may experience mild adverse reactions. These include nausea, constipation, dizziness, or abdominal discomfort. Serious side effects are uncommon, but it is essential to monitor for signs of allergic reactions or unusual symptoms. Due to its minimal absorption, rifaximin has a low risk of disrupting natural microbiota balance in the long term, although repeated courses should be monitored carefully.
Considerations and Precautions
Patients should always follow their healthcare provider’s instructions when using rifaximin. It is vital to complete the prescribed course, even if symptoms improve early. Misuse or incomplete treatment can lead to bacterial resistance, making future infections harder to treat. Rifaximin is usually safe for most people, but those with a history of hypersensitivity to rifamycins should avoid it. Pregnant and breastfeeding women should consult their doctor before use, as safety data is limited in these groups. Additionally, individuals with compromised immune systems or liver conditions should discuss potential risks with their healthcare provider.
Conclusion
Overall, rifaximin is a highly effective and generally safe antibiotic option for treating various gastrointestinal infections and conditions. Its targeted mechanism offers the benefit of infection control with minimal systemic absorption, reducing the likelihood of widespread side effects. While it provides significant relief for many patients, proper medical guidance is essential to ensure safe and effective use. For those suffering from conditions like traveler’s diarrhea, hepatic encephalopathy, or IBS-D, rifaximin can be a valuable part of their treatment plan, improving symptoms and enhancing daily comfort.